Ashton Thomas Private Wealth LLC Makes New Investment in Everus (NYSE:ECG)

Ashton Thomas Private Wealth LLC bought a new position in shares of Everus (NYSE:ECGFree Report) in the fourth quarter, Holdings Channel reports. The firm bought 3,776 shares of the company’s stock, valued at approximately $248,000.

A number of other large investors have also recently added to or reduced their stakes in the stock. SRS Capital Advisors Inc. bought a new stake in Everus during the fourth quarter worth approximately $26,000. Principal Securities Inc. bought a new stake in Everus during the fourth quarter worth approximately $27,000. HighMark Wealth Management LLC bought a new stake in Everus during the fourth quarter worth approximately $28,000. Crews Bank & Trust bought a new stake in Everus during the fourth quarter worth approximately $29,000. Finally, Mendota Financial Group LLC bought a new stake in shares of Everus in the fourth quarter valued at approximately $36,000.

Everus Price Performance

ECG opened at $37.72 on Wednesday. Everus has a 1-year low of $37.18 and a 1-year high of $77.93. The company has a 50 day simple moving average of $59.51. The company has a debt-to-equity ratio of 0.47, a current ratio of 1.58 and a quick ratio of 1.50.

Everus (NYSE:ECGGet Free Report) last issued its earnings results on Tuesday, February 11th. The company reported $0.67 EPS for the quarter, missing the consensus estimate of $0.73 by ($0.06). Equities research analysts predict that Everus will post 2.49 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, CFO Maximillian J. Marcy bought 1,300 shares of Everus stock in a transaction that occurred on Tuesday, February 25th. The stock was purchased at an average cost of $38.99 per share, with a total value of $50,687.00. Following the completion of the transaction, the chief financial officer now directly owns 5,508 shares in the company, valued at $214,756.92. This trade represents a 30.89 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Edward A. Ryan bought 1,400 shares of Everus stock in a transaction that occurred on Tuesday, February 25th. The stock was purchased at an average cost of $38.02 per share, with a total value of $53,228.00. Following the completion of the transaction, the director now owns 14,928 shares of the company’s stock, valued at $567,562.56. This trade represents a 10.35 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders bought a total of 3,750 shares of company stock valued at $153,853 over the last ninety days.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on ECG. Stifel Nicolaus reduced their price objective on Everus from $85.00 to $67.00 and set a “buy” rating for the company in a research report on Thursday, February 13th. Oppenheimer increased their price objective on Everus from $70.00 to $80.00 and gave the company an “outperform” rating in a research report on Tuesday, January 7th. Finally, Wolfe Research began coverage on Everus in a research report on Tuesday, December 3rd. They issued a “peer perform” rating for the company.

View Our Latest Stock Analysis on ECG

About Everus

(Free Report)

Everus Construction Group is providing a full spectrum of construction services through its electrical and mechanical and transmission and distribution specialty contracting services principally in United States. Its specialty contracting services are provided to utility, transportation, commercial, industrial, institutional, renewable and other customers.

Featured Stories

Want to see what other hedge funds are holding ECG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Everus (NYSE:ECGFree Report).

Institutional Ownership by Quarter for Everus (NYSE:ECG)

Receive News & Ratings for Everus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Everus and related companies with MarketBeat.com's FREE daily email newsletter.